| Authors: |
Leonard RA; Department of Molecular Genetics and Microbiology, Duke University School of Medicine Durham, Durham, NC, USA., Burke KN; Department of Molecular Genetics and Microbiology, Duke University School of Medicine Durham, Durham, NC, USA., Spreng RL; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA., Macintyre AN; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Tam Y; Acuitas Theraputics, Vancouver, BC, Canada., Alameh MG; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Children's Hospital of Pennsylvania, Philadelphia, PA, USA.; Department of Medicine, Institute for RNA Innovation, Perelman School of Medicine, Philadelphia, PA, USA., Weissman D; Department of Medicine, Institute for RNA Innovation, Perelman School of Medicine, Philadelphia, PA, USA., Heaton NS; Department of Molecular Genetics and Microbiology, Duke University School of Medicine Durham, Durham, NC, USA. nicholas.heaton@duke.edu.; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA. nicholas.heaton@duke.edu. |
